Lindbrook Capital, LLC Kala Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$1.16 - $2.74 $11,310 - $26,715	-9,750 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$5.06 - $8.15 $22,026 - $35,476	4,353 Added 80.66%	9,750 $52,000
Q1 2021 Apr 28, 2021	SELL	$6.24 - $9.58 $25,072 - $38,492	-4,018 Reduced 42.68%	5,397 $36,000
Q4 2020 Jan 27, 2021	BUY	$6.28 - $8.79 $18,840 - $26,369	3,000 Added 46.77%	9,415 $64,000
Q3 2020 Nov 03, 2020	BUY	$7.5 - $11.11 $16,192 - $23,986	2,159 Added 50.73%	6,415 $48,000
Q2 2020 Jul 27, 2020	SELL	$8.33 - $13.79 $58,260 - $96,447	-6,994 Reduced 62.17%	4,256 $45,000
Q1 2020 Apr 22, 2020	BUY	$3.83 - $8.79 $43,087 - $98,887	11,250 New	11,250 $99,000
Q1 2019 Apr 23, 2019	SELL	$5.19 - $8.97 $23,355 - $40,365	-4,500 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$4.29 - $9.94 $19,305 - $44,730	4,500 New	4,500 $22,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $11.3M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.